Piper Sandler analyst Matt O'Brien weighs in on MedTech stocks following the ADA conference.The analyst commented: "We met with six ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE